BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36608422)

  • 1. ERAP2 supports TCR recognition of three immunotherapy targeted tumor epitopes.
    Schmidt K; Leisegang M; Kloetzel PM
    Mol Immunol; 2023 Feb; 154():61-68. PubMed ID: 36608422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separate effects of the ankylosing spondylitis associated ERAP1 and ERAP2 aminopeptidases determine the influence of their combined phenotype on the HLA-B*27 peptidome.
    Martín-Esteban A; Sanz-Bravo A; Guasp P; Barnea E; Admon A; López de Castro JA
    J Autoimmun; 2017 May; 79():28-38. PubMed ID: 28063628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ER Aminopeptidases, ERAP1 and ERAP2, synergize to self-modulate their respective activities.
    Martín-Esteban A; Rodriguez JC; Peske D; Lopez de Castro JA; Shastri N; Sadegh-Nasseri S
    Front Immunol; 2022; 13():1066483. PubMed ID: 36569828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERAP1 enzyme-mediated trimming and structural analyses of MHC I-bound precursor peptides yield novel insights into antigen processing and presentation.
    Li L; Batliwala M; Bouvier M
    J Biol Chem; 2019 Dec; 294(49):18534-18544. PubMed ID: 31601650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ER-aminopeptidase 1 determines the processing and presentation of an immunotherapy-relevant melanoma epitope.
    Textoris-Taube K; Cammann C; Henklein P; Topfstedt E; Ebstein F; Henze S; Liepe J; Zhao F; Schadendorf D; Dahlmann B; Uckert W; Paschen A; Mishto M; Seifert U
    Eur J Immunol; 2020 Feb; 50(2):270-283. PubMed ID: 31729751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of ERAP1 and ERAP2 genes and their disfunction in human cancer.
    Compagnone M; Cifaldi L; Fruci D
    Hum Immunol; 2019 May; 80(5):318-324. PubMed ID: 30825518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERAP1-ERAP2 dimerization increases peptide-trimming efficiency.
    Evnouchidou I; Weimershaus M; Saveanu L; van Endert P
    J Immunol; 2014 Jul; 193(2):901-8. PubMed ID: 24928998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redundancy and Complementarity between ERAP1 and ERAP2 Revealed by their Effects on the Behcet's Disease-associated HLA-B*51 Peptidome.
    Guasp P; Lorente E; Martín-Esteban A; Barnea E; Romania P; Fruci D; Kuiper JW; Admon A; López de Castro JA
    Mol Cell Proteomics; 2019 Aug; 18(8):1491-1510. PubMed ID: 31092671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERAP1-ERAP2 dimers trim MHC I-bound precursor peptides; implications for understanding peptide editing.
    Chen H; Li L; Weimershaus M; Evnouchidou I; van Endert P; Bouvier M
    Sci Rep; 2016 Aug; 6():28902. PubMed ID: 27514473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editing the immunopeptidome of melanoma cells using a potent inhibitor of endoplasmic reticulum aminopeptidase 1 (ERAP1).
    Koumantou D; Barnea E; Martin-Esteban A; Maben Z; Papakyriakou A; Mpakali A; Kokkala P; Pratsinis H; Georgiadis D; Stern LJ; Admon A; Stratikos E
    Cancer Immunol Immunother; 2019 Aug; 68(8):1245-1261. PubMed ID: 31222486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8 T cell function and cross-reactivity explored by stepwise increased peptide-HLA versus TCR affinity.
    Baumgaertner P; Schmidt J; Costa-Nunes CM; Bordry N; Guillaume P; Luescher I; Speiser DE; Rufer N; Hebeisen M
    Front Immunol; 2022; 13():973986. PubMed ID: 36032094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERAP1-Dependent Antigen Cross-Presentation Determines Efficacy of Adoptive T-cell Therapy in Mice.
    Schmidt K; Keller C; Kühl AA; Textor A; Seifert U; Blankenstein T; Willimsky G; Kloetzel PM
    Cancer Res; 2018 Jun; 78(12):3243-3254. PubMed ID: 29559473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative expression profiling for human endoplasmic reticulum-resident aminopeptidases 1 and 2 in normal kidney versus distinct renal cell carcinoma subtypes.
    Stoehr CG; Buettner-Herold M; Kamphausen E; Bertz S; Hartmann A; Seliger B
    Int J Clin Exp Pathol; 2013; 6(6):998-1008. PubMed ID: 23696916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERAP, KIR, and HLA-C Profile in Recurrent Implantation Failure.
    Piekarska K; Radwan P; Tarnowska A; Wiśniewski A; Radwan M; Wilczyński JR; Malinowski A; Nowak I
    Front Immunol; 2021; 12():755624. PubMed ID: 34745129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To Be or Not to Be: The Case of Endoplasmic Reticulum Aminopeptidase 2.
    Kuśnierczyk P
    Front Immunol; 2022; 13():902567. PubMed ID: 35769458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shedding new light on the role of ERAP1 in Type 1 diabetes: A perspective on disease management.
    Paldino G; Fierabracci A
    Autoimmun Rev; 2023 Apr; 22(4):103291. PubMed ID: 36740089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoplasmic reticulum aminopeptidase 1 polymorphism Ile276Met is associated with atopic dermatitis and affects the generation of an HLA-C associated antigenic epitope in vitro.
    Niepiekło-Miniewska W; Mpakali A; Stratikos E; Matusiak Ł; Narbutt J; Lesiak A; Kuna P; Wilczyńska K; Nowak I; Wiśniewski A; Zwolińska K; Ponińska J; Płoski R; Szepietowski JC; Kuśnierczyk P
    J Eur Acad Dermatol Venereol; 2019 May; 33(5):906-911. PubMed ID: 30680818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-Specific and Variant-Linked Alterations in Expression of ERAP1, ERAP2, and LNPEP Aminopeptidases in Psoriasis.
    Marusina AI; Ji-Xu A; Le ST; Toussi A; Tsoi LC; Li Q; Luxardi G; Nava J; Downing L; Leal AR; Kuzminykh NY; Kruglinskaya O; Brüggen MC; Adamopoulos IE; Merleev AA; Gudjonsson JE; Maverakis E
    J Invest Dermatol; 2023 Jul; 143(7):1157-1167.e10. PubMed ID: 36716917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of the 'Mis-Peptidome' on HLA Class I-Mediated Diseases: Contribution of ERAP1 and ERAP2 and Effects on the Immune Response.
    Tedeschi V; Paldino G; Paladini F; Mattorre B; Tuosto L; Sorrentino R; Fiorillo MT
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of endoplasmic reticulum aminopeptidases in EBV-B cell lines from healthy donors and in leukemia/lymphoma, carcinoma, and melanoma cell lines.
    Fruci D; Ferracuti S; Limongi MZ; Cunsolo V; Giorda E; Fraioli R; Sibilio L; Carroll O; Hattori A; van Endert PM; Giacomini P
    J Immunol; 2006 Apr; 176(8):4869-79. PubMed ID: 16585582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.